Abiopharma

🔍 Baker Jeff (Executive)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 12,500 shares of Class A Common Stock (Direct)
  Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 49,289.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 6,760 shares of Class A Common Stock at $107.87 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 42,529.00 | transaction_form_type: 4
• Sold 12,500 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 112,500.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.
• F2: The award vested as to 1/4 of the total award on July 29, 2025, and vests as to 1/16 of the total award thereafter on the 29th calendar day of October, January, April, and July, subject to the reporting person's continued service to the Issuer on each vesting date.
• F3: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.